Collectively, these findings uncover persistent or resurgent MM cells as an important factor for sustained immune perturbation in the BM, and suggest that blood measurements, specifically CXCR3 expression on T cells, may be used as accessible biomarkers to track environmental perturbations associated with future relapse. Here, CXCR3 is linked to Miyoshi myopathy.